This is a Phase 1, single-center, dose-escalations (SAD and MAD) and food effect study of FCN-207:~Part 1 Single Ascending Dose (SAD) study: randomized, double-blind, placebo-controlled.~Part 2 Food-effect study: single-dose, two-treatment (fasted vs. high-fat meal), two-sequence crossover design.~Part 3 Multiple Ascending Dose (MAD) study: randomized, double-blind, placebo-controlled.
This research study is studying an investigational drug called FCN-207 in healthy adult males or females.